US › Healthcare

Cumberland Pharmaceuticals Inc (CPIX)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$5.22+4.19%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$166,458

Revenue YoY

-98.5%

Net profit

$-4.1M

EPS

$-0.20

Net margin

-2,472.5%

Key statistics

Market cap

$75.1M

Forward P/E

50.0

P/B

3.85

Book value

$1.16

EPS (TTM)

$-0.62

52-week high

$9.28

52-week low

$1.13

50-day MA

$6.90

200-day MA

$5.51

Beta

0.26

Analyst view

with an average price target of $8.50.

Shareholding

Insiders

41.60%

Institutions

16.65%

Largest institutional holders

Fund	Stake
Ikarian Capital, LLC	3.36%
Renaissance Technologies Corp	3.19%
Vanguard Capital Management, LLC	2.53%
Dimensional Fund Advisors, Inc.	1.56%
BOOTHBAY FUND MANAGEMENT, LLC	0.75%
Geode Capital Management, LLC	0.72%
Perceptive Advisors LLC	0.65%
Citadel Advisors Llc	0.49%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Cumberland Pharmaceuticals Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.